PADI3 and arthropathy: Additional support for anti-PAD4 antibodies being amplifiers of disease, rather than causes of ACPA-positive RA, comes from the discovery of serum anti-PAD3/4 antibodies that are associated with disease duration and severe joint disease in RA patients [2].